Clinical Trial Update: Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 Vaccine [Phase 3]

View source ↗

Summary

Phase 3 trial results for GlaxoSmithKline's HPV-16/18 vaccine (Cervarix) in young adolescent women were completed and results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Intraepithelial Neoplasia
• Human Papillomavirus Infection

Drugs mentioned

• Cervarix (human papillomavirus vaccine, bivalent)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Cervical Intraepithelial Neoplasia, Papillomavirus Infection | Phase 3 | Status: COMPLETED | Results posted: 2010-03-01